RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cambridge Cognition Holdings Stock

Cambridge Cognition Holdings Stocks 2024

Cambridge Cognition Holdings Stocks

34.6 M

Ticker

COG.L

ISIN

GB00B8DV9647

WKN

A1T9LW

In 2024, Cambridge Cognition Holdings had 34.6 M outstanding stocks, a 0% change from the 34.6 M stocks in the previous year.

The Cambridge Cognition Holdings Stocks history

YEARNUMBER OF STOCKS (undefined GBP)
2026e34.6
2025e34.6
2024e34.6
202334.6
202231.18
202131.53
202029.78
201923.41
201820.55
201720.4
201619.47
201516.83
201416.44
201313.42
20125.98
20114.94
20105.23

Cambridge Cognition Holdings shares outstanding

The number of shares was Cambridge Cognition Holdings in 2023 — This indicates how many shares 34.597 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cambridge Cognition Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cambridge Cognition Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cambridge Cognition Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cambridge Cognition Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cambridge Cognition Holdings Aktienanalyse

What does Cambridge Cognition Holdings do?

Cambridge Cognition Holdings PLC is a British company specializing in the development of computer programs for cognitive assessment of patients in medical research and development. The company was founded in 1986 by a group of neuroscientists from the University of Cambridge, who aimed to conduct neuropsychological research in standardized and automated form. The development of tests that could be conducted on computers was intended to increase the accuracy and efficiency of neuropsychological assessment of patients. The business quickly grew into a successful company, and Cambridge Cognition Holdings PLC was listed on the London Stock Exchange in 2013. The core business of the company is to provide tests and tools for assessing the cognitive functions of patients in medical research and development. Cambridge Cognition's products and services can be divided into two main categories: cognitive tests and digital therapeutic interventions. Cambridge Cognition's cognitive tests include a variety of specialized tests designed to assess the cognitive functions of patients. These tests cover areas such as memory, attention, executive function, and fine motor skills. The tests can be conducted on desktop computers, tablets, or mobile devices, offering standardization, efficiency, and reproducibility in the assessment of patients' cognitive functions. Another branch of the company is the development of digital therapeutic interventions. These interventions are designed to improve or maintain the cognitive functions of patients by triggering specific brain activities. An example of this is the "CogniFit" program for improving the cognitive abilities of older people. By using computer-based tests, the program aims to enhance users' cognitive functions and help slow down cognitive decline in old age. Cambridge Cognition Holdings PLC is not only involved in medical research but also in the pharmaceutical industry. The company offers services to pharmaceutical companies for conducting clinical studies testing the effectiveness of new drugs on cognitive functions. The combination of Cambridge Cognition's cognitive tests with clinical research provides an accurate assessment of the impact of medications on patients' cognitive functions. Cambridge Cognition's business model is based on the development and marketing of cognitive tests and digital therapeutic interventions. The company collaborates with medical research and development departments of pharmaceutical companies, academic institutions, and clinics. It also provides services related to clinical research to evaluate the effectiveness of new drugs on cognitive functions. Overall, Cambridge Cognition Holdings PLC is a leading company in medical research and development. Through the development of cognitive tests and digital therapeutic interventions, the company can contribute to improving patients' cognitive functions and accelerate the development of new medical therapies. Cambridge Cognition Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Cambridge Cognition Holdings's Shares Outstanding

Cambridge Cognition Holdings's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Cambridge Cognition Holdings’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Cambridge Cognition Holdings’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Cambridge Cognition Holdings’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Cambridge Cognition Holdings stock

How many stocks are there of Cambridge Cognition Holdings?

The current number of stocks of Cambridge Cognition Holdings is 34.6 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Cambridge Cognition Holdings are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Cambridge Cognition Holdings evolved in recent years?

The number of shares of Cambridge Cognition Holdings has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Cambridge Cognition Holdings as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Cambridge Cognition Holdings?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Cambridge Cognition Holdings pay?

Over the past 12 months, Cambridge Cognition Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cambridge Cognition Holdings is expected to pay a dividend of 0 GBP.

What is the dividend yield of Cambridge Cognition Holdings?

The current dividend yield of Cambridge Cognition Holdings is .

When does Cambridge Cognition Holdings pay dividends?

Cambridge Cognition Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cambridge Cognition Holdings?

Cambridge Cognition Holdings paid dividends every year for the past 0 years.

What is the dividend of Cambridge Cognition Holdings?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cambridge Cognition Holdings located?

Cambridge Cognition Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cambridge Cognition Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cambridge Cognition Holdings from 8/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 8/31/2024.

When did Cambridge Cognition Holdings pay the last dividend?

The last dividend was paid out on 8/31/2024.

What was the dividend of Cambridge Cognition Holdings in the year 2023?

In the year 2023, Cambridge Cognition Holdings distributed 0 GBP as dividends.

In which currency does Cambridge Cognition Holdings pay out the dividend?

The dividends of Cambridge Cognition Holdings are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cambridge Cognition Holdings

Our stock analysis for Cambridge Cognition Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cambridge Cognition Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.